FDA Approved: AMMONIA N 13 — Original Application (SOFIE Co. dba SOFIE)

View source ↗

Summary

FDA approved the original application for AMMONIA N 13 from SOFIE, a radiopharmaceutical used in PET imaging to assess myocardial perfusion.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Coronary Artery Disease
• Ischemic Heart Disease

Drugs mentioned

• AMMONIA N 13 (NH3N13)

Snippet

ORIG AP for AMMONIA N 13 (AMMONIA N-13)